MedTrace Logo

Effectiveness Of Suprachoroidal Injection In Diabetic Macular Edema

NCT06449768 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 36

Last updated 2024-06-10

No results posted yet for this study

Summary

It will investigate a novel treatment approach for diabetic macular edema (DME), which causes vision impairment in diabetic patients. It will focuse on the efficacy and safety of administering triamcinolone acetonide via suprachoroidal injection, targeting the space between the sclera and choroid.

Conditions

Interventions

BEHAVIORAL

Diabetic Macular Edema

observing the eye behavior in Diabetic Macular Edema

Sponsors & Collaborators

  • Superior University

    lead OTHER

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-01
Primary Completion
2024-05-01
Completion
2024-10-28

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06449768 on ClinicalTrials.gov